Birdwatch Note
2024-12-18 02:22:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
なぜ高くなったかという点に関して同様の公開CNから抜粋します。 https://x.com/i/birdwatch/t/1855959942131495125 ワクチンは販売量が低下し商用化する中で米国で成人の民間の接種費用が2万円程(保険なし)、英国で最大2万円等と大幅値上げされ、日本同様です。 https://www.cdc.gov/vaccines-for-children/php/awardees/current-cdc-vaccine-price-list.html https://www.bbc.com/news/health-55045639 それでも、モデルナ・ビオンテックは今期赤字予想となっており、暴利を得ている訳でもありません。 https://www.nikkei.com/nkd/company/us/BNTX/finance/ https://www.nikkei.com/nkd/company/us/MRNA/finance/ ここまで なぜ高くなったかは国内外の記事で既に多数説明されており、一般に商品の販売価格には、原価の他に流通・開発・固定費等があり、販売量が低下した場合には、薄利多売ができませんので、同じ価格では売れません。 https://answers.ten-navi.com/pharmanews/22591/ https://pharmaphorum.com/news/pfizer-plans-considerable-2023-comirnaty-markup
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1869189780103401617
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1869206598582948201
- noteId - 1869206598582948201
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1734488555939
- tweetId - 1869189780103401617
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- なぜ高くなったかという点に関して同様の公開CNから抜粋します。 https://x.com/i/birdwatch/t/1855959942131495125 ワクチンは販売量が低下し商用化する中で米国で成人の民間の接種費用が2万円程(保険なし)、英国で最大2万円等と大幅値上げされ、日本同様です。 https://www.cdc.gov/vaccines-for-children/php/awardees/current-cdc-vaccine-price-list.html https://www.bbc.com/news/health-55045639 それでも、モデルナ・ビオンテックは今期赤字予想となっており、暴利を得ている訳でもありません。 https://www.nikkei.com/nkd/company/us/BNTX/finance/ https://www.nikkei.com/nkd/company/us/MRNA/finance/ ここまで なぜ高くなったかは国内外の記事で既に多数説明されており、一般に商品の販売価格には、原価の他に流通・開発・固定費等があり、販売量が低下した場合には、薄利多売ができませんので、同じ価格では売れません。 https://answers.ten-navi.com/pharmanews/22591/ https://pharmaphorum.com/news/pfizer-plans-considerable-2023-comirnaty-markup
Note Ratings
| rated at | rated by | |
| 2024-12-18 11:03:47 -0600 | Rating Details | |
| 2024-12-18 10:17:17 -0600 | Rating Details | |
| 2024-12-18 04:00:54 -0600 | Rating Details | |
| 2024-12-18 02:53:32 -0600 | Rating Details | |
| 2024-12-18 02:39:46 -0600 | Rating Details | |
| 2024-12-18 02:20:14 -0600 | Rating Details | |
| 2024-12-18 02:04:16 -0600 | Rating Details | |
| 2024-12-18 01:53:52 -0600 | Rating Details | |
| 2024-12-18 01:53:46 -0600 | Rating Details | |
| 2024-12-18 01:45:46 -0600 | Rating Details | |
| 2024-12-18 01:21:39 -0600 | Rating Details | |
| 2024-12-18 01:19:12 -0600 | Rating Details | |
| 2024-12-18 00:19:15 -0600 | Rating Details | |
| 2024-12-18 00:07:06 -0600 | Rating Details | |
| 2024-12-17 23:04:24 -0600 | Rating Details | |
| 2024-12-17 22:07:31 -0600 | Rating Details | |
| 2024-12-17 22:05:43 -0600 | Rating Details | |
| 2024-12-17 22:04:21 -0600 | Rating Details | |
| 2024-12-17 22:01:09 -0600 | Rating Details | |
| 2024-12-17 21:54:32 -0600 | Rating Details | |
| 2024-12-17 21:21:24 -0600 | Rating Details | |
| 2024-12-17 20:51:07 -0600 | Rating Details | |
| 2024-12-17 20:49:54 -0600 | Rating Details | |
| 2024-12-20 16:40:32 -0600 | Rating Details | |
| 2024-12-23 18:19:51 -0600 | Rating Details | |
| 2024-12-18 09:11:09 -0600 | Rating Details | |
| 2024-12-18 02:42:30 -0600 | Rating Details | |
| 2024-12-18 00:11:36 -0600 | Rating Details | |
| 2024-12-17 23:47:11 -0600 | Rating Details | |
| 2024-12-17 22:41:22 -0600 | Rating Details | |
| 2024-12-17 22:40:28 -0600 | Rating Details | |
| 2024-12-17 21:46:07 -0600 | Rating Details | |
| 2024-12-17 21:30:27 -0600 | Rating Details | |
| 2024-12-17 21:00:51 -0600 | Rating Details | |
| 2024-12-17 20:40:46 -0600 | Rating Details | |
| 2024-12-17 20:39:05 -0600 | Rating Details | |
| 2024-12-17 20:26:36 -0600 | Rating Details | |
| 2024-12-19 04:58:34 -0600 | Rating Details | |
| 2024-12-18 05:27:20 -0600 | Rating Details | |
| 2024-12-18 03:22:27 -0600 | Rating Details | |
| 2024-12-18 02:44:43 -0600 | Rating Details | |
| 2024-12-18 01:53:56 -0600 | Rating Details | |
| 2024-12-18 01:53:17 -0600 | Rating Details | |
| 2024-12-17 23:56:15 -0600 | Rating Details | |
| 2024-12-17 23:37:40 -0600 | Rating Details | |
| 2024-12-17 23:36:38 -0600 | Rating Details | |
| 2024-12-17 21:40:28 -0600 | Rating Details | |
| 2024-12-17 21:31:50 -0600 | Rating Details | |
| 2024-12-17 21:04:06 -0600 | Rating Details |